96 related articles for article (PubMed ID: 10657849)
21. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
[TBL] [Abstract][Full Text] [Related]
22. [Autoantibodies to glutamate decarboxylase in children with newly detected insulin-dependent diabetes mellitus].
Trofimenko EV; Zlobina EV; Lebedev NV; Martynova MI; Piliutik VF; Shchegol'kova TS; Zlobina EN; Dedov II
Probl Endokrinol (Mosk); 1994; 40(2):18-21. PubMed ID: 8197083
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
[TBL] [Abstract][Full Text] [Related]
24. Complement-fixing islet cell antibodies in type-1 diabetes can trigger the assembly of the terminal complement complex on human islet cells and are potentially cytotoxic.
Radillo O; Nocera A; Leprini A; Barocci S; Mollnes TE; Pocecco M; Pausa M; Valente U; Betterle C; Tedesco F
Clin Immunol Immunopathol; 1996 Jun; 79(3):217-23. PubMed ID: 8635278
[TBL] [Abstract][Full Text] [Related]
25. [Islet autoantibody assays in type I diabetes: superiority of passage from use of ICA to traditional tests].
Lazar D; Weintrob N; Abramov N; Assa S; Bloch K; Ofan R; Ben-Zaken H; Vardi P
Harefuah; 1998 May; 134(9):678-81, 750. PubMed ID: 10909610
[TBL] [Abstract][Full Text] [Related]
26. Lack of specificity of islet cell surface antibodies (ICSA) in IDDM.
Peterson C; Campbell IL; Harrison LC
Diabetes Res Clin Pract; 1992 Jul; 17(1):33-42. PubMed ID: 1511659
[TBL] [Abstract][Full Text] [Related]
27. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
[TBL] [Abstract][Full Text] [Related]
29. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes.
Daw K; Powers AC
Diabetes; 1995 Feb; 44(2):216-20. PubMed ID: 7532143
[TBL] [Abstract][Full Text] [Related]
30. Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.
Veijola R; Vähäsalo P; Tuomilehto-Wolf E; Reijonen H; Kulmala P; Ilonen J; Akerblom HK; Knip M
Diabetes; 1995 Sep; 44(9):1021-8. PubMed ID: 7657023
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
[TBL] [Abstract][Full Text] [Related]
32. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
Ongagna JC; Levy-Marchal C
Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
[TBL] [Abstract][Full Text] [Related]
34. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.
Passini N; Larigan JD; Genovese S; Appella E; Sinigaglia F; Rogge L
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9412-6. PubMed ID: 7568143
[TBL] [Abstract][Full Text] [Related]
35. Anti-pancreatic immunity. In vitro studies of cellular and humoral immune reactions directed toward pancreatic islets.
Boitard C; Saï P; Debray-Sachs M; Assan R; Hamburger J
Clin Exp Immunol; 1984 Mar; 55(3):571-80. PubMed ID: 6368060
[TBL] [Abstract][Full Text] [Related]
36. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.
Sugihara S; Sakamaki T; Konda S; Murata A; Wataki K; Kobayashi Y; Minamitani K; Miyamoto S; Sasaki N; Niimi H
Diabetes; 1997 Nov; 46(11):1893-7. PubMed ID: 9356042
[TBL] [Abstract][Full Text] [Related]
37. Insulin secretion by pancreas of athymic mice injected with peripheral mononuclear cells from insulin-dependent diabetic patients.
Arata M; Fabiano de Bruno L; Goncalvez Volpini W; Gagliardi G; Quintans CJ; Basabe JC
Metabolism; 1995 Nov; 44(11):1435-41. PubMed ID: 7476331
[TBL] [Abstract][Full Text] [Related]
38. Detection of glutamic acid decarboxylase (GAD) autoantibodies by indirect immunofluorescence using CHO cells expressing recombinant human GAD65.
Papouchado ML; Ermácora MR; Poskus E
J Autoimmun; 1996 Oct; 9(5):689-97. PubMed ID: 8933286
[TBL] [Abstract][Full Text] [Related]
39. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry.
Vandewalle CL; Falorni A; Svanholm S; Lernmark A; Pipeleers DG; Gorus FK
J Clin Endocrinol Metab; 1995 Mar; 80(3):846-51. PubMed ID: 7883841
[TBL] [Abstract][Full Text] [Related]
40. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.
Lan MS; Wasserfall C; Maclaren NK; Notkins AL
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6367-70. PubMed ID: 8692821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
